Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
113
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension

Naka Shiratori1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, JapanCorrespondence[email protected]
,
Yusuke Nishio1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, Japan
,
Ayaka Takeda1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, Japan
,
Shio Sugimoto1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan;2 Shinanozaka Clinic, Tokyo, Japan
,
Kenji Takazawa2 Shinanozaka Clinic, Tokyo, Japan
,
Naomi Otsuka3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan
,
Naruhiro Ishida3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan
,
Daisuke Shii3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan
,
Kiyotaka Hori3 Japan Medical Affairs Group, Santen Pharmaceutical Co. Ltd., Osaka, Japan
&
Kenji Nakamoto1 Department of Ophthalmology, Nippon Medical School, Tokyo, Japan
 show all
Pages 3997-4003 | Published online: 04 Oct 2021

References

  • Heijl A, Leske M, Bengtsson B, et al.; Early manifest glaucoma trial group. Reduction of intraocular pressure and glaucoma progression: result from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268
  • Leske M, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48–56. doi:10.1001/archopht.121.1.48
  • Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open glaucoma. Arch Ophthalmol. 2002;120(6):701–713. doi:10.1001/archopht.120.6.701
  • Mansouri K, Tanna AP, DeMoraes CG, et al. Review of the measurement and management of 24-hour intraocular pressure in patients with glaucoma. Surv Ophthalmol. 2020;65:171–186. doi:10.1016/j.survophthal.2019.09.004
  • Liu JHK, Medeiros FA, Slight JR, et al. Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure. Ophthalmology. 2010;117(11):2075–2079. doi:10.1016/j.ophtha.2010.03.026
  • Gulati V, Fan S, Zhao M, et al. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy. Arch Ophthalmol. 2012;130(6):677–684. doi:10.1001/archophthalmol.2011.2573
  • Orzalesi N, Rossetti L, Bottoli A, et al. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma and ocular hypertension. Ophthalmology. 2006;113(2):239–246. doi:10.1016/j.ophtha.2005.10.045
  • Oddone F, Rossetti L, Tanga L, et al. Effects of topical bimatoprost 0.01% and timolol 0.5% on circadian IOP, blood pressure and perfusion pressure in patients with glaucoma or ocular hypertension: a randomized, double masked, placebo-controlled clinical trial. PLoS One. 2015;10(10):e0140601. doi:10.1371/journal.pone.0140601
  • Aihara M, Lu F, Kawata H, et al. Omidenepag isopropyl versus latanoprost in primary open-angle glaucoma and ocular hypertension: the Phase 3 AYAME study. Am J Ophthalmol. 2020;220:53–63. doi:10.1016/j.ajo.2020.06.003
  • Aihara M, Lu F, Kawata H, et al. Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE study. Jpn J Ophthalmol. 2021:1–10. doi:10.1007/s10384-021-00868-y
  • Aihara M, Ropo A, Lu F, et al. Intraocular-pressure lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-glaucoma or ocular hypertension: the FUJI study. Jpn J Ophthalmol. 2020;64(4):398–406. doi:10.1007/s10384-020-00748-x
  • Inoue K, Inoue J, Kunimatsu-Sanuki S, et al. Short-term efficacy and safety of omidenepag isopropyl in patients with normal tension glaucoma. Clin Ophthalmol. 2020;14:2943–2949. doi:10.2147/OPTH.S271789
  • Nakakura S, Kanamori A, Fukuma Y, et al. Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study. BMJ Open. 2021;11(1):e040301. doi:10.1136/bmjopen-2020-040301
  • Aihara M, Aung T, Bacharach J, et al. Omidenepag isopropyl ophthalmic solution for open-angle glaucoma and ocular hypertension: an update. Expert Rev Ophthalmol. 2021;16(4):243–250. doi:10.1080/17469899.2021.1935241
  • Okuno T, Sugiyama T, Kohyama M, et al. Ocular blood flow changes after dynamic exercise in humans. Eye. 2006;20:796–800. doi:10.1038/sj.eye.6702004
  • Quatanta L, Katsanos A, Russo A, et al. 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. Surv Ophthalmol. 2013;58(1):26–41. doi:10.1016/j.survophthal.2012.05.003
  • Liu JHK, Kripke DF, Twa MD, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999;40(12):2439–2442.
  • Barkana Y, Anis S, Liebmann J, et al. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol. 2006;124(6):793–797. doi:10.1001/archopht.124.6.793
  • Kim HJ, Cho BJ. Long-term effect of latanoprost on central cornea thickness in normal tension glaucoma. J Ocul Pharmacol Ther. 2011;27(1):73–76. doi:10.1089/jop.2010.0071
  • Zheng X, Wang Y, Zhao Y, et al. Experimental evaluation of latanoprost-induced changes in biomechanical behavior of ex-vivo rabbit corneas. Curr Eye Res. 2019;44(1):19–24. doi:10.1080/02713683.2018.1516781

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.